🟦 Non-Member Event : 2023 Partners Physician Academy
Date: September 18th - 22nd Click here for info.
All members have the option of attending our various HTC-centric events which include:
Date: September 18th - 22nd Click here for info.
Date: Wednesday, September 20, 2023 Time: 1:00pm - 2:00pm ET TITLE: Case Discussion: Adult Severe Type 3 von Willebrand Disease Patient OBJECTIVE: In case you missed it at the National Bleeding Disorders Foundation conference, join expert Dr. Jonathan Roberts, MD for an interactive discussion about managing patients who are living with von Willebrand Disease (VWD). Read the full article...
Date: Wednesday, October 4, 2023 Time: 1:00pm - 2:00pm ET TITLE: An injectable, extended half-life recombinant, glycopegylated factor VIII concentrate for Hemophilia A OBJECTIVE: Provide a clinical overview of Esperoct that supports prophylactic, on-demand and perioperative management indications in adults and children. TARGET AUDIENCE: All HTC Staff SPEAKER: Parin Chikani, PharmD, MBA Medical Account Director, Read the full article...
Venue: The St. Anthony Hotel Location: San Antonio, Texas Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568. DRAFT AGENDA: Oct. 8th – Welcome Reception @ 6pm Oct. 9th – Breakfast @ 7:30am; Meeeting: 8:30am – 5:00pm; Group Dinner @ 6:30 pm Oct. 10th - Breakfast @ 7:30am; Meeeting: 8:30am Read the full article...
Date: Thursday, October 12, 2023 Time: 1:00pm - 2:00pm ET TITLE: A Label Update on Rebinyn, (Coagulation Factor IX (Recombinant), GlycoPEGylated: FDA Approval for a Prophylaxis Indication for Persons with Hemophilia B OBJECTIVE: Provide a clinical review of Rebinyn that supports prophylaxis, on-demand and perioperative indication in adults and children TARGET AUDIENCE: All HTC Staff Read the full article...